Product Information
AMLODIPINE-VALSARTAN 5-160 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2758 per EA under NDC 00378172193. Its NADAC has been published 591 times since Apr 29, 2015.
FDA first approved this application on Mar 30, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 160 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378172193
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA090483FDA Approved
3/30/2015
TE Code
AB
On Market Since
3/30/2015
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN 5-160 MG has been published 591 times since Apr 29, 2015, and over the history we have for it it has declined 93.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2758 per EA |
|---|---|
| All-time high | $4.2444 (Jun 10, 2015) |
| All-time low | $0.2758 (Aug 19, 2026) |
| 52-week high | $0.4927 |
| 52-week low | $0.2758 |
| Median price | $0.4623 |
| Average price | $0.5144 |
| Largest weekly change | -66.9% (Jul 22, 2015) |
| Weeks tracked | 591 |
| Tracking since | Apr 29, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the AMLODIPINE AND VALSARTAN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN 5-160 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 5-160 MG, manufactured by Mylan Pharmaceuticals Inc., is $0.2758 per EA (NDC 00378172193), effective Aug 19, 2026.
How has the price of AMLODIPINE-VALSARTAN 5-160 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has declined 93.5%. It has been tracked across 591 weekly CMS publications since Apr 29, 2015.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 5-160 MG?
Since Apr 29, 2015, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has ranged from a low of $0.2758 (Aug 19, 2026) to a high of $4.2444 (Jun 10, 2015), with a median of $0.4623 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN 5-160 MG?
No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-VALSARTAN 5-160 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-VALSARTAN 5-160 MG?
AMLODIPINE-VALSARTAN 5-160 MG (NDC 00378172193) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.